Xylem: Fundamentals Are Not Bad, But I Still Don't See A Bargain (NYSE:XYL)

Xylem maintains a ‘Hold’ rating due to a lack of growth catalysts justifying its premium valuation despite Q1 revenue growth of 3% to $2.13B. While the company initiated a $1.5B share repurchase program and increased dividends, rising short-term debt of $531M poses a temporary constraint on further buybacks. XYL’s margins and ROE lag peers, and without a clear re-rating catalyst, medium-term upside appears limited.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin